Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Axcel in connection with the combination of itm8 and its current portfolio company AddPro
Mandate

Vinge advises Axcel in connection with the combination of itm8 and its current portfolio company AddPro

May 30, 2022 M&A

Axcel, in partnership with Chr. Augustinus Fabrikker, has agreed to acquire the Danish digital transformation partner, itm8, to create a northern European group within end-to-end IT services through a combination with Axcel-owned AddPro.

Over the years, itm8 and AddPro have individually built strong brands and the aim is to jointly expand the offering of IT-services in the northern European area. Vinge assisted Axcel as lead legal advisor in regard to the divestment of AddPro and Swedish law aspects of the combination with itm8.

The transaction is subject to customary regulatory approvals and is expected to close in Q3 2022.

Vinge’s team consisted of Christina Kokko, Johanna Wiberg, Viktor Lennartsson and Nina Fathjalali (M&A), and Viktoria Owetz Leyva, Sara Dahlros Sköld, Christoffer Widström, Julia Hagelberg and Klara Lundquist (VDR).

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026